The House passed legislation that would give federal workers 12 weeks of paid parental leave. The measure appears headed for passage in the Senate, and President Donald Trump has promised to sign the measure into law. Meanwhile, House and Senate lawmakers have a tentative deal on surprise medical bills, but don’t count on a compromise just yet. Joanne Kenen of Politico, Kimberly Leonard of the Washington Examiner and Emmarie Huetteman of Kaiser Health News join guest host Mary Agnes Carey of KHN to discuss this and more. And for “extra credit,” the panelists offer their favorite health stories of the week they think you should read, too.
Open enrollment for the Affordable Care Act’s marketplace plans is halfway over and, so far, the number of people signing up is down, but not dramatically. Meanwhile, Congress and President Donald Trump can’t seem to agree on what to do about teen vaping, drug prices or “surprise” medical bills. And Democrats lurch to the left on abortion. Paige Winfield Cunningham of The Washington Post, Kimberly Leonard of the Washington Examiner and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss this and more health news.
Texas passed a bipartisan law against surprise medical billing, but advocates warn that a proposed rule could severely weaken it, continuing to allow surprise bills outside of emergencies.
Other states may follow California’s new law requiring later start times for middle and high school students. The new law highlights the importance of better sleep, which will once again be on people’s minds as most of America — but not all — sets the clock back an hour early next month.
Many states have rules that keep parents from knowing about or consenting to certain types of care for their children, including mental health and drug and alcohol treatment. Washington state, however, has revised its policies.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
Pharmaceutical companies raised the wholesale cost of their drugs by a median of nearly 26% from 2017 to early 2019, according to California’s first-ever report stemming from a new drug price transparency law. Prices for generic drugs rose nearly 38% during that time.
The new law reclassifies many independent contractors as employees, requiring they be offered a range of benefits. But that could have unintended consequences, experts warn.
Washington is abuzz with impeachment talk, but what impact would such a move have on congressional action on prescription drug prices and surprise bills? Also, a study out this week shows that health insurance costs for both employers and workers continue to rise. This week, Joanne Kenen of Politico, Paige Winfield Cunningham of The Washington Post and Rebecca Adams of CQ Roll Call join KHN’s Julie Rovner to discuss these issues and more.
The House speaker announced her plan for lowering drug prices, which includes negotiations between drugmakers and federal health officials.